Blanchard Jm
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Blanchard Jm.
Cytogenetic and Genome Research | 1994
Cai Qq; Ariane Plet; Jean Imbert; Lafage-Pochitaloff M; Cerdan C; Blanchard Jm
Ku protein is a relatively abundant DNA-binding nuclear protein complex composed of two polypeptide subunits, p70 and p80. Ku has been recently identified as the regulatory component of the DNA-dependent protein kinase that phosphorylates RNA polymerase II. To further characterize in vivo regulation of Ku protein, we studied the expression of the transcripts coding for the Ku p70 and p80 subunits in different human cell lines and normal tissues by Northern blot hybridization, using specific cDNA probes. The expression level of both genes was approximately 10-fold higher in established cell lines than in normal tissues. However, mRNA expression levels in permanent cell lines correlated more strongly with their proliferative state than with their level of malignant transformation. In purified T lymphocytes induced to proliferate by the combined action of monoclonal antibodies directed against the CD2 and CD28 adhesion molecules, Ku p70 and p80 mRNA steady-state levels increased as soon as 6 h after activation and lasted at least 72 h. The human genes coding for the Ku p70 and p80 subunits were localized by cytogenetic mapping, using fluorescence in situ hybridization, to 22q13 and 2q33-->q35, respectively.
Biology of the Cell | 1992
Ariane Plet; Tourkine N; N. Mechti; Ph. Jeantheur; Blanchard Jm
Assuming that when transcription starts at the P2 promoter of the c-myc gene sites located immediately upstream from P2 are occupied whereas in the absence of initiation they are not, the polymerase chain reaction (PCR)-based method of Mueller & Wold [(1989). Science, 246, 780-786] was used to map in vivo footprints upstream from the P2 promoter in various mouse cell lines. In cultured Friend erythroleukemic cells induced to differentiate with dimethysulfoxide (DMSO), a clear protection corresponding to ME1a2 and E2F sites was observed, consistent with in vitro band-shift and footprint data. However, in cell lines in which the gene was either silent or truncated the footprints were no longer visible. Friend c-myc transcripts decreased to a barely detectable level after 3 h of DMSO treatment. Transcription, as measured by in vitro run-on, was turned off at the level of RNA polymerase elongation rather than initiation [Mechti N., Piechaczyk, M. Blanchard, J.-M., Marty, L., Bonnieu, A., Jeanteur, Ph. & Lebler, B. (1986). Nucleic Acids Res., 24, 9653-9666]. The state of occupancy of the sites did not vary from the first hours up to 9 days of DMSO treatment, suggesting that DNA occupancy per se cannot explain premature termination, which rather would involve a more complex phenomenon.
Nucleic Acids Research | 1985
Ph. Fort; Louise Marty; Marc Piechaczyk; S.El Sabrouty; Ch. Dani; Ph. Jeanteur; Blanchard Jm
Proceedings of the National Academy of Sciences of the United States of America | 1985
C.-H. Dani; Nadir Mechti; Marc Piechaczyk; Bernard Lebleu; Philippe Jeanteur; Blanchard Jm
Molecular and Cellular Biology | 1996
Xavier Huet; Jocelyne Rech; Ariane Plet; Annick Vié; Blanchard Jm
Biochemical and Biophysical Research Communications | 1984
F. Panabières; Marc Piechaczyk; B. Rainer; Ch. Dani; Ph. Fort; S. Riaad; Louise Marty; J.L. Imbach; Ph. Jeanteur; Blanchard Jm
Oncogene | 1995
Ariane Plet; Eick D; Blanchard Jm
Molecular and Cellular Biology | 1991
Nadir Mechti; Marc Piechaczyk; Blanchard Jm; Philippe Jeanteur; Bernard Lebleu
Nucleic Acids Research | 1986
Nadir Mechti; Marc Piechaczyk; Blanchard Jm; Louise Marty; Anne Bonnieu; Ph. Jeanteur; Bernard Lebleu
Oncogene | 1995
Jean-Luc Veyrune; Carillo S; Annick Vié; Blanchard Jm